Unique ID issued by UMIN | UMIN000037739 |
---|---|
Receipt number | R000042791 |
Scientific Title | Identification of gene polymorphisms that predict the efficacy and safety of nivolumab treatment for renal cancer |
Date of disclosure of the study information | 2019/08/20 |
Last modified on | 2020/08/19 15:07:57 |
Identification of gene polymorphisms that predict the efficacy and safety of nivolumab treatment for renal cancer
SNiP-RCC
Identification of gene polymorphisms that predict the efficacy and safety of nivolumab treatment for renal cancer
SNiP-RCC
Japan |
Renal cell cancer
Urology |
Malignancy
YES
To identify genetic polymorphisms that predict the efficacy and safety of nivolumab treatment for renal cancer by genome-wide analysis on single-nucleotide polymorphism (SNP).
Others
To carry out genome-wide SNP analysis of genome DNA extracted from blood specimen using Japonica array.
Others
Not applicable
SNPs that correlate with tumor response to nivolumab
SNPs that correlate with progression , treatment continuation and overall survival in nivolumab treatment SNPs that correlate with adverse events in nivolumab treatment
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients who were treated or are planned to be treated with nivolumab for advanced renal cancer
2.Patients diagnosed with clear cell carcinoma pathologically
3.Patients with at least one measurable lesion according to RECIST v1.1 criteria
4.Patients who fully understand this research plan and can give their consent
5.Japanese people over 20 years of age at the time of consent acquisition
1.non-Japanese patients
2.Patients in whom the evaluation of response rate according to RECIST ver.1.1 is not carried out within 24 weeks after the start of treatment
3.Patients who received nivolumab as first line treatment
4.Patients who co-administered with drugs for renal cancer other than nivolumab
5.Patients who are judged inappropriate for participation in this study
200
1st name | Masatoshi |
Middle name | |
Last name | Eto |
Graduate School of Medical Sciences, Kyushu University
Department of Urology
812-8582
3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan
092-642-5601
etom@uro.med.kyushu-u.ac.jp
1st name | Masaki |
Middle name | |
Last name | Shiota |
Kyushu University Hospital
Department of Urology
812-8582
3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan
092-642-5603
shiota@uro.med.kyushu-u.ac.jp
Graduate School of Medical Sciences, Kyushu University
ONO PHARMACEUTICAL CO., LTD.
Bristol-Myers Squibb K.K.
Profit organization
(Not for public release)Entered
(Not for public release)Entered
(Not for public release)Entered
(Not for public release)Entered
NO
北海道大学大学院医学研究科(北海道)、札幌医科大学医学部(北海道)、弘前大学大学院医学研究科(青森県)、岩手医科大学医学部(岩手県)、山形大学医学部(山形県)、新潟大学大学院医歯学総合研究科(新潟県)、慶應義塾大学医学部(東京都)、防衛医科大学校(埼玉県)、浜松医科大学医学部(静岡県)、名古屋大学大学院医学系研究科(愛知県)、京都大学大学院医学研究科(京都府)、大阪大学大学院医学系研究科(大阪府)、近畿大学医学部(大阪府)、奈良県立医科大学(奈良県)、神戸大学大学院医学研究科(兵庫県)、広島市立安佐市民病院(広島県)、山口大学大学院医学系研究科(山口県)、徳島大学大学院医歯薬学研究部(徳島県)、国立病院機構四国がんセンター(愛媛県)、九州大学大学院医学研究院(福岡県)、熊本大学大学院生命科学研究部(熊本県)、長崎大学大学院医歯薬学総合研究科(長崎県)、宮崎大学医学部(宮崎県)、鹿児島大学大学院医歯学総合研究科(鹿児島県)
2019 | Year | 08 | Month | 20 | Day |
Unpublished
Open public recruiting
2019 | Year | 04 | Month | 24 | Day |
2019 | Year | 08 | Month | 19 | Day |
2019 | Year | 09 | Month | 06 | Day |
2021 | Year | 03 | Month | 31 | Day |
1.Extraction of DNA from blood specimen.
2. SNP analysis using Japonica array.
3.Individual SNP analysis using PCR method.
4.Statistical analysis of correlation with clinical information.
2019 | Year | 08 | Month | 20 | Day |
2020 | Year | 08 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042791
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |